Aquestive Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BRATTON CAPITAL MANAGEMENT, L.P. | 02/13/2025 | 9.81 M | $34.93 M | 0.00% | 10.77% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 6.00 M | $21.36 M | 3.01% | 6.59% |
| VANGUARD GROUP INC | 02/11/2025 | 4.35 M | $15.47 M | 1.95% | 4.77% |
| VR ADVISER, LLC | 02/14/2025 | 2.63 M | $9.36 M | -52.66% | 2.89% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 2.13 M | $7.60 M | -22.84% | 2.34% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.65 M | $5.89 M | -0.77% | 1.82% |
| BIOIMPACT CAPITAL LLC | 02/14/2025 | 1.61 M | $5.74 M | -10.29% | 1.77% |
| STATE STREET CORP | 02/14/2025 | 1.50 M | $5.35 M | 0.48% | 1.65% |
| BLUE OWL CAPITAL HOLDINGS LP | 02/14/2025 | 900,000 | $3.20 M | -26.53% | 0.99% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 876,537 | $3.12 M | 293.62% | 0.96% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 02/07/2025 | 623,310 | $2.22 M | -11.85% | 0.68% |
| PALE FIRE CAPITAL SE | 02/13/2025 | 525,756 | $1.87 M | 2,090.65% | 0.58% |
| BRACEBRIDGE CAPITAL, LLC | 02/14/2025 | 459,216 | $1.63 M | 7.15% | 0.50% |
| UBS GROUP AG | 02/14/2025 | 420,563 | $1.50 M | 363.74% | 0.46% |
| WOODLINE PARTNERS LP | 02/14/2025 | 409,314 | $1.46 M | -49.85% | 0.45% |
| STIFEL FINANCIAL CORP | 02/13/2025 | 398,561 | $1.42 M | 315.41% | 0.44% |
| TORNO CAPITAL, LLC | 02/14/2025 | 398,100 | $1.42 M | 100.00% | 0.44% |
| HARVEY CAPITAL MANAGEMENT INC | 01/29/2025 | 267,390 | $951,908 | 1,419.26% | 0.29% |
| LATASH INVESTMENTS, LLC | 02/12/2025 | 243,134 | $865,557 | 0.00% | 0.27% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 236,473 | $841,844 | 0.00% | 0.26% |
| 02/12/2025 | 216,223 | $769,754 | -45.96% | 0.24% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 210,669 | $749,982 | 3.50% | 0.23% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 193,874 | $690,191 | 25.05% | 0.21% |
| LEGATO CAPITAL MANAGEMENT LLC | 01/29/2025 | 186,424 | $663,669 | -23.08% | 0.20% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 179,612 | $639,419 | -3.01% | 0.20% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 175,952 | $626,389 | 31.51% | 0.19% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 171,681 | $611,184 | -3.38% | 0.19% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 160,380 | $798,692 | 0.00% | 0.18% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 160,000 | $569,600 | 100.00% | 0.18% |
| CAHILL WEALTH MANAGEMENT, LLC | 02/13/2025 | 143,051 | $509,262 | 0.08% | 0.16% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 140,889 | $501,565 | -50.12% | 0.15% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 139,591 | $497,670 | 100.00% | 0.15% |
| ENTRYPOINT CAPITAL, LLC | 02/11/2025 | 135,797 | $483,437 | 475.73% | 0.15% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 127,000 | $452,120 | -78.46% | 0.14% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 126,464 | $450,212 | 307.34% | 0.14% |
| BARCLAYS PLC | 02/13/2025 | 118,711 | $422,000 | 19.53% | 0.13% |
| AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 114,994 | $409,378 | -12.08% | 0.13% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/13/2025 | 108,513 | $386,305 | 59.84% | 0.12% |
| RHUMBLINE ADVISERS | 01/30/2025 | 106,957 | $380,759 | 3.14% | 0.12% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 95,400 | $339,624 | 233.57% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 87,700 | $312,212 | -79.60% | 0.10% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 87,227 | $310,528 | 111.20% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 82,600 | $294,056 | -43.89% | 0.09% |
| HIGHTOWER ADVISORS, LLC | 02/07/2025 | 79,636 | $283,504 | -26.27% | 0.09% |
| FMR LLC | 02/13/2025 | 75,645 | $269,295 | 13,882.44% | 0.08% |
| JPMORGAN CHASE & CO | 02/12/2025 | 75,500 | $268,780 | 67.65% | 0.08% |
| CREATIVE PLANNING | 02/14/2025 | 75,355 | $268,264 | -18.82% | 0.08% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 72,507 | $258,000 | 52.57% | 0.08% |
| AQUATIC CAPITAL MANAGEMENT LLC | 02/14/2025 | 62,612 | $222,899 | 400.90% | 0.07% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 61,989 | $220,681 | 63.91% | 0.07% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aquestive Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 144 institutional investors and hedge funds held shares of Aquestive Therapeutics, Inc.. The most heavily invested institutionals were:
Bratton Capital Management, L.P.: 9.81 M
BlackRock Funding, Inc. /DE: 6 M
VANGUARD GROUP INC: 4.35 M
VR Adviser, LLC: 2.63 M
FRANKLIN RESOURCES INC: 2.13 M
GEODE CAPITAL MANAGEMENT, LLC: 1.65 M
47.62% of Aquestive Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 48.28 M shares in the last 24 months. This purchase volume represents approximately $159.32 M in transactions.